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Even though syphilis can be easily diagnosed by simple and low-cost laboratory methods, it continues 
to be an important health problem. Rapid tests (RT) for the detection of treponemal antibodies can 
facilitate earlier diagnosis, access to treatment and linkage to care. The aim of this study was to analyse 
the usefulness of the incorporation of a RT in the detection of patients infected with T. pallidum in a 
sexually-transmitted disease (STD) clinic. Between March and December 2015, a syphilis RT was offered 
to patients who spontaneously attended the clinic. Conventional serology testing was additionally 
indicated to every participant. The RT for syphilis was offered to 1887 patients, of whom 31.1% agreed 
to get tested. VDRL test was performed in 84.0% of patients that were also tested with syphilis RT, 
with a significantly higher frequency observed among participants with reactive RT (94.3% vs. 79.8%, 
p < 0.001). These results showed that 33.7% of the participants were reactive for the RT and 27.0% 
were reactive for the VDRL test. Both tests were reactive in 24.9% and non-reactive in 64.3%. A high 
prevalence of active syphilis was detected in patients attending the clinic. The use of a syphilis RT had a 
positive impact, which in combination with the VDRL test increased the number of patients that were 
effectively diagnosed.
Syphilis is a sexually-transmitted disease (STD) caused by the spirochaete Treponema pallidum subspecies pal-
lidum (T. pallidum). Most infected individuals are unaware of their infection while transmission to their sexual 
contacts effectively occurs. When this infection goes undiagnosed and untreated, it can lead to long-term devel-
opment of serious manifestations in the cardiovascular system (cardiovascular syphilis), the central nervous sys-
tem (neurosyphilis), as well as granulomatous lesions (syphilitic gumma)1,2. Moreover, infected pregnant women 
can transmit T. pallidum to the foetus leading to serious consequences like intrauterine foetal death, neonatal 
death and congenital syphilis3. In addition, syphilis can cause genital ulcers, which have been associated with an 
increase in HIV transmission risk2,4. Therefore, early detection and treatment are fundamental in the prevention 
and control of syphilis and serious long-term complications in persons with syphilis as well as congenital syphilis.
Syphilis can be diagnosed by a combination of simple and low-cost laboratory methods and it has been effi-
ciently treated since the discovery of penicillin at the beginning of the 20th century2. However, it continues to be 
an important health problem. According to the World Health Organization, Latin America and the Caribbean 
is the region with the highest incidence of syphilis worldwide, concentrating three of 12 million new infections5.
The global prevalence of syphilis in Argentina is unknown but. However, several studies conducted within the 
country found a high prevalence among vulnerable populations. Among men who have sex with men (MSM) in 
Buenos Aires City, the prevalence of syphilis ranged from 16.9% to 20.5%6,7, whereas 22.4% of syphilis infection 
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was detected among female sex workers in eight major cities of Argentina8 and a 50% prevalence was found 
among female transgender sex workers in the City of Buenos Aires9.
The detection of non-treponemal (anti-cardiolipin antibodies) and treponemal antibodies is still the mainstay 
of syphilis diagnosis. Treponemal antibodies can be detected in all the stages of syphilis and are used mainly to 
confirm the infection. On the other hand, non-treponemal antibodies are used in syphilis screening to monitor 
the status of the infection as well as the response to antibiotic treatment10.
Recently, syphilis rapid tests (RT) for the detection of treponemal antibodies have become commercially avail-
able in Argentina. This kind of RT can expand the range of settings in which syphilis testing can be undertaken, 
thus facilitating earlier diagnosis, access to rapid treatment and linkage to care10,11. Nevertheless, there is still no 
local experience on its use and on its usefulness for the detection of infected patients in need of treatment.
The sexually-transmitted disease clinic at the University Hospital (Hospital de Clínicas “José de San Martín”, 
Programa de Enfermedades de Transmisión Sexual, PETS) receives approximately 250 patients’ consultations per 
month, 45% of whom are MSM. A year previous to this study, syphilis was the second most prevalent infectious 
disease detected among patients attending the clinic, accounting for 11.4% of all detected infections, after human 
papillomaviruses (18%) (Ricardo Casco, personal communication). The aim of this study was to analyse the 
usefulness of the incorporation of a syphilis RT for the detection of patients infected with T. pallidum by its imple-
mentation in this STD clinic.
Results
Characteristics of the study group. During the study period, RT for syphilis was offered to 1887 patients 
who spontaneously attended the STD clinic, whereas 587 of them agreed to get tested (31.1%) (Fig. 1). Table 1 
shows socio-demographic characteristics of the study population. Briefly, participants’ median age was 29 years 
and 78.6% of them were male. Most participants resided in Buenos Aires City (72.2%) or its surroundings in the 
Buenos Aires Province, whereas participants from other provinces and foreigners were rare. Seventy-five percent 
of the study population had completed high school and less than 40% reported having a steady job position. 
According to the participant’s medical records, around 78% of them reported having an appointment with a 
Figure 1. Flowchart showing the flow of participants attending the STD clinic in Buenos Aires, Argentina 
(2015). Sample size for each step throughout the study is shown.
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physician in the previous year. In relation to the type of partner, 96.9% of the female participants reported having 
male partners. However, 50.2% of the men reported having male partners. Condom use was mostly irregular, with 
only 26.2% of the study participants reporting regular use.
Analysis of RT results. Of the 587 participants recruited in this study, 493 (84.1%) attended the university 
hospital laboratory for VDRL testing, with this frequency being significantly higher among participants with 
reactive RT (94.3% vs. 79.8%, p < 0.001).
The analysis of the RT and VDRL results showed that 33.7% (166/493) of participants turned out to be reactive 
for the RT and 27.0% (133/493) were reactive for VDRL, with both tests being reactive in 123 cases (24.9%). A 
total of 317 (64.3%) participants were found to be non-reactive in both tests. RT and VDRL test results are sum-
marized in Table 2 and Fig. 1.
In 43 participants, a reactive RT but a non-reactive VDRL test was obtained, 32 of whom (74.4%) had a previ-
ous history of syphilis infection stated in their medical records. Of the 11 participants that did not have a recorded 
history of syphilis infection, two were considered to be false-positive in the RT because treponemal antibodies 
were not detected by the indirect immunofluorescence test (FTA-Abs) and the treponemal hemagglutination 
assay (TPHA), leaving nine cases unsolved, given the fact that the participants did not return to the STD clinic 
for their follow-up.
In a total of 10 participants a reactive VDRL test but a non-reactive RT was obtained. In these cases, VDRL 
titres ranged from one to four. In six of these cases, syphilis diagnosis was excluded as a non-reactive result was 
obtained in the VDRL, FTA-Abs and TPHA tests in a second serum sample obtained during the follow-up visit. 
Nevertheless, one of these participants was diagnosed with primary syphilis infection as revealed by positive 
Total N = 586 With VDRL test N = 493 Without VDRL test N = 93
Median age (IQR) 29 (24–38) 29 (24–37) 30 (24–40)
Gender % (n/N)
Male 78.6% (456/580) 79.5% (388/488) 73.9% (68/92)
Female 21.4% (124/580) 20.5% (100/488) 26.1% (24/92)
Residence
City of Buenos Aires 72.2% (345/478) 72.0% (293/407) 73.2% (52/71)
Outside the city 27.8% (133/478) 28.0% (114/407) 26.8% (19/71)
Formal Education level
Complete high school 75.0% (436/581) 74.0% (362/489) 80.4% (74/92)
Incomplete high school 25.0% (145/581) 26.0% (127/489) 19.6% (18/92)
Employment status
Have an steady job 38.9% (218/561) 37.2% (175/470) 47.3% (43/91)
Unsteady job or unemployed 61.1% (343/561) 62.8% (295/470) 52.7% (48/91)
Last visit to a doctor
<1 year 78.5% (427/544) 79.3% (363/458) 74.4% (64/86)
>1 year 21.5% (117/544) 20.7% (95/458) 25.6% (22/86)
Type of sex partners in the last six months
Men (n = 434)
    Only women 49.8% (216/434) 47.0% (174/370) 65.6% (42/64)*
    Only men or men and women 50.2% (218/434) 53.0% (196/370) 34.4% (22/64)
Women (n = 118)
    Only men 96.9% (114/118) 95.8% (91/95) 100% (23/23)
    Only women or men and women 3.4% (4/118) 4.2% (4/95) 0% (0/23)
Condom use
Regular 26.2% (144/550) 26.5% (123/465) 24.7% (21/85)
Irregular 73.8% (406/550) 73.5% (342/465) 75.3% (64/85)
Table 1. Socio-demographic characteristics of 586 participants attending the STD clinic in Buenos Aires, 
Argentina (2015). Stratification by VDRL test done. *p < 0.05.
VDRL Reactive RT N (%) Non-reactive RT N (%) Total N (%)
Reactive 123 (24.9) 10 (2.0) 133 (27.0)
Non-reactive 43 (8.7) 317 (64.3) 360 (73.0)
Total 166 (33.7) 327 (66.3) 493
Table 2. Syphilis Rapid Test and VDRL test results in 493 participants attending the STD clinic in Buenos Aires, 
Argentina (2015).
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dark-field microscopy obtained from material of a lesion. In this case, the non-reactive RT was considered as 
a false-negative result. The three remaining cases could not be elucidated since participants failed to attend 
a follow-up visit. Reasons for not returning to the follow-up visit or not getting the VDRL test are unknown. 
During this study, no further changes were introduced in the standard of care, and patients were free to decide 
what test they would get and whether they would return to the clinic for further consultation. Comparing 
socio-demographic characteristics of the study population stratified by VDRL test done or not done, we identi-
fied that men who have female partners attend the clinic for a follow-up less frequently than those men who have 
male partners (Table 1).
Syphilis prevalence. Syphilis prevalence according to the syphilis RT results, which detects both current 
and past infection, was 33.7% (166/493). Nevertheless, prevalence of active syphilis, i.e. participants with both 
reactive RT and VDRL test, was 24.9% (123/493) (Table 1). This prevalence was significantly higher when com-
pared to that of the previous year (11.4%, 156/1364, p < 0.001). All patients with active syphilis received treatment 
for free and were followed up using VDRL.
Discussion
Several cheap and simple rapid tests for syphilis are available worldwide and represent an opportunity to expand 
syphilis diagnosis in hard-to-reach populations who are less likely to return to care. Moreover, it has been 
reported that the sensitivity of the syphilis RT varies between 60–89% when using whole blood while specificity 
of the RT were higher than 98%11. However, international literature agrees with the need for additional clinical, 
performance and cost effectiveness assessments in relation to the implementation of RT in different settings10.
This study reports, for the first time in Argentina, the usefulness of the RT performed within an STD clinic on 
detecting patients infected with Treponema pallidum. Before this study, the STD clinic’s standard of care was to 
screen the patients’ lesions for syphilis by dark-field microscopy when present while offering the non-treponemal 
antibody test to all of them. In 2014, the year prior to that of the current study, syphilis prevalence was 11.4%, 
using the standard of care. During the study period, the RT was offered to every patient attending the STD clinic 
but only 31.1% agreed to get tested. Frequent reasons for not getting tested were ‘I am on treatment for syphilis’, ‘I 
already had syphilis’, ‘The visit to the STD clinic was to retrieve syphilis test results’ and ‘I want to discuss RT for 
syphilis with a physician first’. Nevertheless, a high prevalence of active syphilis was detected (24.9%) combining 
VDRL and RT results, and a positive effect of the rapid testing was observed in participants with reactive RT, 
since they were tested by VDRL more often than participants with non-reactive RT (93.4% vs. 79.8%, p < 0.001). 
This might be due to the physician’s strong recommendation to perform VDRL test on participants with positive 
syphilis RT and no history of syphilis in their medical records. Also, having to wait for blood extraction at the 
lab might play a role in the participant’s decision. Therefore, in this context, the introduction of RT together with 
clinical evaluation and VDRL test increased the diagnostic opportunity of syphilis and the establishment of an 
effective treatment with penicillin as all positive patients were treated for free in the STD clinic.
The rapid turnaround time for results (15 minutes), the type of specimen used (fingerstick whole blood), 
and the fact that it can be performed and interpreted by personnel with basic training in testing procedures and 
biosafety measures are some of the advantages of the RT. Nevertheless, it has been suggested that due to the fact 
that this type of test can be performed by non-laboratory experienced personnel, the interpretation of the results 
can vary with the subjectivity of the operator. Moreover, variability among test lots, day-to-day interpretation 
and differences between operators have been documented10–13. In addition, sensitivity variations of the syphilis 
RT were observed in several studies using whole blood11,12 but in our study, a low number of false-positive cases 
was detected using whole blood on site. To reduce bias, only two experienced lab operators who received specific 
training on test procedures by trainers from the National Ministry of Health performed and interpreted all the 
tests and no invalid tests were obtained. Treatment of all RT positive individuals will result in over-treatment, 
mainly due to the fact that the RT detects treponemal specific antibodies, and thus it cannot distinguish between 
active and past treated infection, and to a lesser extent, to the presence of false-positive RT results. However, given 
the serious consequences of missed treatment, in high prevalence settings with poor linkage to health care, the 
benefits of treatment far outweigh the cost of over-treatment. To hamper this situation, the VDRL test was recom-
mended to every patient in our study and approximately a quarter of the participants with reactive RT (43/166) 
did not have active syphilis and in their medical records stated history of syphilis and treatment. The decision to 
refer or not to immediate treatment was made by the physician based on the combination of the participant’s STD 
history, clinical examination and VDRL test results. Treatment with penicillin is offered and administered for free 
at the STD clinic, and in a handful of cases, treatment was discontinued upon obtaining the VDRL test result. 
Furthermore, in this group, only two false-positive RT were detected as non-treponemal antibodies by VDRL test 
and treponemal antibodies by TPHA, and FTA-Abs were non-reactive.
On the other hand, in a few participants with a non-reactive RT (3.1%, n = 10), a reactive VDRL test was 
obtained with titres ranging from one to four. In this group, syphilis was discarded in six cases because trepone-
mal antibodies were not detected (neither by TPHA nor by FTA-Abs test). False-positive VDRL test results can 
be attributed to the presence of anti-cardiolipin antibodies that are not related to syphilis infection but present in 
other infectious diseases (e.g. malaria, leprosy, Chagas disease, tuberculosis and hepatitis C, among others), or 
other conditions (autoimmune diseases, pregnancy, old age or malignant diseases)10,14. Even more importantly, 
we identified a case of primary syphilis in a participant with a lesion in the genital region compatible with a syph-
ilitic chancre which had not been detected by RT. In this case, non-treponemal and treponemal antibodies were 
detected by VDRL test and FTA-Abs test, respectively. Thus, it was considered false negative by RT. This patient 
was treated with penicillin and VDRL tests were used to monitor treatment efficacy. Our results are concordant 
with previous studies, suggesting that RT can be used in syphilis diagnosis with similar sensitivity and specificity 
to other treponemal tests11,12.
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A limitation of our study was that 11 patients failed to return to the STD clinic for follow-up; thus, a second 
serum sample was not obtained to solve their syphilis status. Loss in follow-up visit might be due to the fact that 
VDRL test results were available within 24 h. This issue could be addressed if VDRL tests were performed within 
the STD clinic but this is not possible in our setting as no laboratory personnel or facilities are available. The dual 
non-treponemal/treponemal RT might help elucidate these cases and in the treatment initiation decision-making. 
Most studies conclude that dual detection of non-treponemal and treponemal antibodies can help detect syphilis 
cases in resource-limited settings while substantially reducing overtreatment rates15,16 but the major limitation of this 
dual non-treponemal/treponemal RT is its low sensitivity shown for low-titre non-treponemal antibodies16–18. High 
sensitivity (98.8%) of this particular RT was observed in a recent study comparing to VDRL tests but limitations were 
that all tests were performed on serum samples and inside conventional laboratory and no biological false-positive 
samples were tested19. This type of RT that detects treponemal and non-treponemal antibodies simultaneously is not 
available in our country yet, and lab performance and field evaluations of this dual point-of-care test are still limited.
In conclusion, a high prevalence of syphilis was detected in patients attending the STD clinic of the university 
hospital, and a low number of false-positive and false-negative RT results was detected in this study. In our setting, 
the use of the RT impacts positively on the diagnosis of syphilis, increasing the treatment opportunity of positive 
patients within the STD clinic. Interventions using RT could provide an opportunity to reduce syphilis prevalence, 
especially in other contexts such as in at-risk populations with documented high prevalence or no linkage to health 
care (e.g. female-, male- or trans-sexual workers) or in prevention strategies aimed at avoiding vertical transmission.
Methods
Study population. Between March and December 2015, RT for syphilis was offered to every patient who 
spontaneously attended the STD clinic of the University Hospital “Hospital de Clínicas, José de San Martín”, 
Universidad de Buenos Aires. Patients who agreed to get tested provided their written informed consent and 
answered a self-administered questionnaire that included several socio-demographic characteristics such as age, 
gender, nationality, level of educational attainment and risk factors for sexually-transmitted diseases such as fre-
quency of condom use. Additionally, participants’ medical records were reviewed in order to gather data concern-
ing reason for consultation, history of syphilis and final clinical diagnosis at recruitment. Patients who refused 
to get tested did not answer the self-administered questionnaire and therefore were excluded from the study. No 
alterations were introduced to the patient’s standard of care other than the incorporation of the syphilis RT.
Ethics Statement. International and national ethical guidelines for biomedical research involving human 
subjects were followed. This study was approved by the University Hospital’s Institutional Review Board (IRB) 
(Comité de Ética, Hospital de Clínicas “José de San Martín”, Universidad de Buenos Aires). The work described was 
carried out in line with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for exper-
iments involving humans. Informed consent was obtained from each participant.
Study procedures. Due to the fact that the RT was used for the first time in the clinic, prior to the initiation 
of the study a single theoretical and practical training session in the use of the RT for the clinic staff and research-
ers involved was carried out by a team of specialists from the National Ministry of Health.
All the individuals who agreed to participate in this study were tested prior to a medical consultation in a 
separate office within the clinic by a trained health professional that received the complete self-administered ques-
tionnaire and explained the test procedures. Fingerstick RT for syphilis was performed on whole blood (Alere 
Determine Syphilis TP) according to the manufacturer´s instructions. The immunochromatographic test was 
used to detect specific antibodies against Treponema pallidum antigens. These antibodies are present in individu-
als with active, past or treated infection. Participants were informed that the results would be explained during the 
medical consultation and that further conventional serology tests for syphilis were likely to be recommended by 
the physician. Test results were available within 15 minutes and linked to the questionnaire by a unique numeric 
code preserving the participant’s confidentiality.
After the clinical evaluation, every participant was asked to go to the university hospital´s laboratory in order 
to obtain a sample of non-anticoagulated blood in sterile conditions using standard safety precautions and pro-
tocols. From this sample, non-treponemal antibodies were detected using the Unheated Serum Reagin (USR) 
test (Wiener Laboratorios, SAIC, Rosario, Argentina) in every participant. The USR test detects anti cardiolipin 
antibodies (non-treponemal antibodies) in non-inactivated serum samples and is performed and interpreted as a 
Venereal Disease Research Laboratory (VDRL) test. In the case of discordant results, treponemal antibodies were 
detected by an indirect immunofluorescence test (FTA-Abs, InmunofluorBiocientifica SA, Argentina) and by 
Treponema pallidum hemagglutination assay (TPHA, BioSystems SA, Barcelona, Spain) in a second serum sample 
obtained at a follow-up visit at the STD clinic.
Statistical analyses. Baseline characteristics were described using medians and interquartile ranges (IQRs) 
for continuous variables, and counts and percentages for categorical data. Comparisons between proportions 
were analysed by parametric and non-parametric methods. Chi-square and Fisher’s exact tests were used to com-
pare differences in categorical variables. Statistical analyses were carried out using IBM SPSS Statistics Base 22.0 
(IBM Corp. Released 2013. IBM SPSS Statistics for Windows, Version 22.0. Armonk, NY: IBM Corp.).
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